CellPoint is a biopharmaceutical company focused on the development of universal molecular imaging compounds and molecular therapeutics for the diagnosis, staging, treatment and treatment monitoring of cancer, cardiovascular disease, and a range of ischemic diseases.
CENTENNIAL, Colorado - CellPoint announced today that it plans to begin patient recruitment for its Phase 2b cardiovascular imaging study in patients ...
Satisfied Users & 
Approved Press Releases
